000 01246 a2200325 4500
005 20250516004635.0
264 0 _c20110512
008 201105s 0 0 eng d
022 _a1573-2665
024 7 _a10.1007/s10545-010-9219-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLinthorst, Gabor E
245 0 0 _aLetter concerning "Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha", by Tanaka et al.
_h[electronic resource]
260 _bJournal of inherited metabolic disease
_cFeb 2011
300 _a237-8 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntibody Formation
_xdrug effects
650 0 4 _aChoice Behavior
650 0 4 _aCross Reactions
650 0 4 _aEnzyme Replacement Therapy
650 0 4 _aFabry Disease
_xblood
650 0 4 _aHumans
650 0 4 _aImmunoglobulin E
_xblood
650 0 4 _aIsoenzymes
_ximmunology
650 0 4 _aMale
650 0 4 _aalpha-Galactosidase
_ximmunology
700 1 _aAerts, Johannes M F G
773 0 _tJournal of inherited metabolic disease
_gvol. 34
_gno. 1
_gp. 237-8
856 4 0 _uhttps://doi.org/10.1007/s10545-010-9219-y
_zAvailable from publisher's website
999 _c20242718
_d20242718